AMIFE, Asociación de medicina de la industria farmacéutica



Secretaría Técnica AMIFE
c/ Cronos, 20, Portal 4, 1º, 6ª Madrid, 28037

Blog

IFAPP – WEBINAR: PATIENTS’ CROSS-BORDER ACCESS TO CLINICAL TRIALS

Categoría 1 10/10/2022

The unmet global need for patients and clinical researchers Date: 17th September, 2024 Time: 01:00 – 02:30 PM CEST (check complete times at the bottom of this post) Patients with life-threatening or rare diseases and patients living inresearch-poor countries are […]

Leer más

IFAPP – WEBINAR: EU – CTR UPDATE WORKSHOP

Categoría 1 10/10/2022

Only 6 months left for transition! Date: 27 June 2024 Time: 12:00 – 02:00 PM CEST The “Clinical Trials Regulation”, Regulation EU 536/2014, has been valid since 31 January 2022 and mandatory since 31 January 2023. The “Transition Period” will […]

Leer más

IFAPP – WEBINAR: EU-CTR UPDATE WORKSHOP

Categoría 1 10/10/2022

Only 6 months left for transition! Date: 27 June 2024 Time: 12:00 – 02: PM CEST The “Clinical Trials Regulation”, Regulation EU 536/2014, has been valid since 31 January 2022 and mandatory since 31 January 2023. The “Transition Period” will […]

Leer más

IFAPP TODAY | MAY 2024 | NUMBER 44

Categoría 1 10/10/2022

Dear IFAPP members, dear colleagues, Please find here enclosed the link to the IFAPP TODAY journal of May 2024. In this issue you will find great contributions from and about: Bernhard Mraz Appointed New President of GPMed, the Austrian IFAPP Member Association Ministries of Health […]

Leer más

IFAPP – WEBINAR: CAR T-CELL THERAPHY AND ETHICAL ASPECTS (PATIENTS’ INVOLVEMENT)

Categoría 1 10/10/2022

Date: Wednesday, May 29, 2024 Time Schedule:05:00 – 07:00 AM EST09:00 – 11:00 AM GMT11:00 – 01:00 PM CEST06:00 – 08:00 PM JST CAR T – Cell Theraphy and Ethical Aspects (patients’ involvement) CAR T-cell therapy has demonstrated high response […]

Leer más

El futuro de los Ensayos Clínicos en la ‘XI Jornadas AECIC’

Categoría 1 10/10/2022

Ya está disponible el programa de la XI Jornada AECIC, cuyo lema este año es ‘El futuro ya presente en Ensayos Clínicos: Actualizacion en IA, tecnología y regulación’.

Leer más

IFAPP – WEBINAR: PATIENTS’ CROSS-BORDER ACCESS TO CLINICAL TRIALS

Categoría 1 10/10/2022

The unmet global need for patients and clinical researchers Date: 17th September, 2024 Time: 01:00 – 02:30 PM CEST (check complete times at the bottom of this post) Patients with life-threatening or rare diseases and patients living inresearch-poor countries are […]

Leer más

IFAPP – WEBINAR: EU – CTR UPDATE WORKSHOP

Categoría 1 10/10/2022

Only 6 months left for transition! Date: 27 June 2024 Time: 12:00 – 02:00 PM CEST The “Clinical Trials Regulation”, Regulation EU 536/2014, has been valid since 31 January 2022 and mandatory since 31 January 2023. The “Transition Period” will […]

Leer más

IFAPP – WEBINAR: EU-CTR UPDATE WORKSHOP

Categoría 1 10/10/2022

Only 6 months left for transition! Date: 27 June 2024 Time: 12:00 – 02: PM CEST The “Clinical Trials Regulation”, Regulation EU 536/2014, has been valid since 31 January 2022 and mandatory since 31 January 2023. The “Transition Period” will […]

Leer más

IFAPP TODAY | MAY 2024 | NUMBER 44

Categoría 1 10/10/2022

Dear IFAPP members, dear colleagues, Please find here enclosed the link to the IFAPP TODAY journal of May 2024. In this issue you will find great contributions from and about: Bernhard Mraz Appointed New President of GPMed, the Austrian IFAPP Member Association Ministries of Health […]

Leer más

IFAPP – WEBINAR: CAR T-CELL THERAPHY AND ETHICAL ASPECTS (PATIENTS’ INVOLVEMENT)

Categoría 1 10/10/2022

Date: Wednesday, May 29, 2024 Time Schedule:05:00 – 07:00 AM EST09:00 – 11:00 AM GMT11:00 – 01:00 PM CEST06:00 – 08:00 PM JST CAR T – Cell Theraphy and Ethical Aspects (patients’ involvement) CAR T-cell therapy has demonstrated high response […]

Leer más

El futuro de los Ensayos Clínicos en la ‘XI Jornadas AECIC’

Categoría 1 10/10/2022

Ya está disponible el programa de la XI Jornada AECIC, cuyo lema este año es ‘El futuro ya presente en Ensayos Clínicos: Actualizacion en IA, tecnología y regulación’.

Leer más